Vedamurthy, M. and Humbert, P. (2018) “A randomized, open label, comparative, five-arm, controlled study evaluating the benefit and tolerability of oral superoxide dismutase combined with gliadin as add-on neutraceutical therapy with standard therapy in Indian patients with melasma”, International Journal of Research in Dermatology, 4(4), pp. 471–478. doi: 10.18203/issn.2455-4529.IntJResDermatol20184453.